Payer National Outcomes Director — VIASKIN Peanut West
DBV Technologies
July 02, 2026
Remote
United States
Market Access
Location: Remote
Salary Range: $200-$240k
Key Responsibilities:
- Act as a subject matter expert on the health outcomes and economic impact of VIASKIN Peanut Patch and the broader peanut allergy treatment landscape.
- Engage with national/regional payers, PBMs, IDNs, employers, and population health key opinion leaders with scientific/clinical/economic information.
- Communicate the value proposition of epicutaneous immunotherapy (efficacy, safety, patch wear-time, real-world relevance) to support coverage/formulary decisions.
- Conduct educational programs, scientific presentations, and value-evidence discussions.
- Build and maintain relationships with external stakeholders (medical/pharmacy directors, payer decision-makers, professional societies, patient advocacy organizations).
- Disseminate health outcomes data, real-world evidence, health economic models, and budget-impact analyses.
- Collaborate with internal cross-functional teams (Market Access, Medical Affairs, Value & Access, Commercial, Field Reimbursement) to align evidence strategy and messaging; experience designing outcomes-based analytics using internal/external data sources (e.g., patient services data, IQVIA, Optum Insights, Komodo).
- Provide training to internal teams on outcomes data and value evidence.
- Respond to unsolicited payer/population health inquiries per applicable regulations and policy.
- Support investigator-initiated studies, real-world evidence generation, and other research.
- Develop strategic plans for health outcomes research, value-evidence communication, and payer engagement; integrate strategies into launch/access/commercialization plans.
Qualifications:
- PharmD, MD, or PhD in a health sciences–related field required; Master’s in pharmacoepidemiology/epidemiology/health economics preferred.
- 8+ years in pharma/biotech/healthcare; 5+ years in HEOR or payer-facing scientific role supporting product launches with U.S. Market Access.
- Experience across medical/scientific affairs, outcomes research, clinical practice, academic, or U.S. managed markets.
- Allergy/immunology and pediatrics and/or rare disease experience preferred; food allergy landscape familiarity strong advantage.
- Strong health outcomes research, epidemiology, health economics, economic modeling, budget-impact analysis, and data analysis expertise.
- Ability to engage national/regional payers/PBMs/IDNs in scientific/value-evidence capacity.
- Excellent communication and presentation skills; proficiency with HEOR regulatory guidelines; strong compliance/ethics understanding.
Behavioral Skills:
- Collaborate cross-functionally; manage multiple projects and priorities.
- Comfortable in an ambiguous, fast-paced, pre-commercial environment.
- Curiosity, courage, credibility, and ability to present to large and small audiences.
Salary Range: $200-$240k
Key Responsibilities:
- Act as a subject matter expert on the health outcomes and economic impact of VIASKIN Peanut Patch and the broader peanut allergy treatment landscape.
- Engage with national/regional payers, PBMs, IDNs, employers, and population health key opinion leaders with scientific/clinical/economic information.
- Communicate the value proposition of epicutaneous immunotherapy (efficacy, safety, patch wear-time, real-world relevance) to support coverage/formulary decisions.
- Conduct educational programs, scientific presentations, and value-evidence discussions.
- Build and maintain relationships with external stakeholders (medical/pharmacy directors, payer decision-makers, professional societies, patient advocacy organizations).
- Disseminate health outcomes data, real-world evidence, health economic models, and budget-impact analyses.
- Collaborate with internal cross-functional teams (Market Access, Medical Affairs, Value & Access, Commercial, Field Reimbursement) to align evidence strategy and messaging; experience designing outcomes-based analytics using internal/external data sources (e.g., patient services data, IQVIA, Optum Insights, Komodo).
- Provide training to internal teams on outcomes data and value evidence.
- Respond to unsolicited payer/population health inquiries per applicable regulations and policy.
- Support investigator-initiated studies, real-world evidence generation, and other research.
- Develop strategic plans for health outcomes research, value-evidence communication, and payer engagement; integrate strategies into launch/access/commercialization plans.
Qualifications:
- PharmD, MD, or PhD in a health sciences–related field required; Master’s in pharmacoepidemiology/epidemiology/health economics preferred.
- 8+ years in pharma/biotech/healthcare; 5+ years in HEOR or payer-facing scientific role supporting product launches with U.S. Market Access.
- Experience across medical/scientific affairs, outcomes research, clinical practice, academic, or U.S. managed markets.
- Allergy/immunology and pediatrics and/or rare disease experience preferred; food allergy landscape familiarity strong advantage.
- Strong health outcomes research, epidemiology, health economics, economic modeling, budget-impact analysis, and data analysis expertise.
- Ability to engage national/regional payers/PBMs/IDNs in scientific/value-evidence capacity.
- Excellent communication and presentation skills; proficiency with HEOR regulatory guidelines; strong compliance/ethics understanding.
Behavioral Skills:
- Collaborate cross-functionally; manage multiple projects and priorities.
- Comfortable in an ambiguous, fast-paced, pre-commercial environment.
- Curiosity, courage, credibility, and ability to present to large and small audiences.